The central sensitization inventory: A user’s manual

Neblett, Randy

doi:10.1111/jabr.12123

Cited by 73 publications

(73 citation statements)

References 78 publications

(142 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The CSI has been psychometrically evaluated in English and other Asian, South American, and European languages. It has been found to be psychometrically sound in all published cross‐cultural studies to the present, with test‐retest reliability coefficients from 0.85 to 0.99 and Cronbach’s alpha from 0.88 to 0.99 5–7 . Evidence of convergent, discriminant, and predictive validity, using both subjective (eg, patient‐reported) and objective (including quantitative sensory testing, brain gamma aminobutyric acid levels, serum brain‐derived neurotrophic factor) CS‐related variables, have been found in a number of previous studies using multiple‐language versions of the CSI 5,8 .…”

Section: Introductionsupporting

confidence: 61%

“…It has been found to be psychometrically sound in all published cross‐cultural studies to the present, with test‐retest reliability coefficients from 0.85 to 0.99 and Cronbach’s alpha from 0.88 to 0.99 5–7 . Evidence of convergent, discriminant, and predictive validity, using both subjective (eg, patient‐reported) and objective (including quantitative sensory testing, brain gamma aminobutyric acid levels, serum brain‐derived neurotrophic factor) CS‐related variables, have been found in a number of previous studies using multiple‐language versions of the CSI 5,8 . Differences in CSI scores have been found among patient groups and healthy controls, as well as among patient subgroups (including those with acute pain, chronic pain, and specific disorders such as fibromyalgia) 5 .…”

Section: Introductionmentioning

confidence: 81%

“…Evidence of convergent, discriminant, and predictive validity, using both subjective (eg, patient‐reported) and objective (including quantitative sensory testing, brain gamma aminobutyric acid levels, serum brain‐derived neurotrophic factor) CS‐related variables, have been found in a number of previous studies using multiple‐language versions of the CSI 5,8 . Differences in CSI scores have been found among patient groups and healthy controls, as well as among patient subgroups (including those with acute pain, chronic pain, and specific disorders such as fibromyalgia) 5 . The questionnaire has demonstrated favorable psychometric properties across cultures 5–8 .…”

Section: Introductionmentioning

confidence: 81%

See 2 more Smart Citations

Convergent and Discriminant Validity of the Serbian Version of the Central Sensitization Inventory

et al. 2020

Self Cite

View full text Add to dashboard Cite

Objectives The goal of the present study was to explore additional evidence of validity of the Serbian version of the Central Sensitization Inventory (CSI), a patient‐reported outcome measure of symptoms that have been found to be associated with central sensitization (CS). The CSI has been found to be psychometrically sound, and has demonstrated evidence of convergent and discriminant validity in numerous published studies and in multiple languages. Methods CSI data were collected from 399 patients with chronic pain who had various diagnoses and from 146 pain‐free controls. In addition, the patient sample completed a battery of validated patient‐reported outcome measures of sleep problems, cognitive problems, pain catastrophizing, pain‐related fear‐avoidance, decreased quality of life, and decreased perception of social support. Six patient subgroups were formed, with presumably different levels of CS (including those with fibromyalgia, multiple pain sites, and localized pain sites). Results Significant differences were found in total CSI scores among the controls and patient subgroups. Those with fibromyalgia and multiple pathologies scored highest and the control subjects scored lowest. Other patient‐reported CS‐related symptom dimensions were significantly correlated with total CSI scores. When the patients were divided into CSI severity subgroups (from subclinical to extreme), the severity of these other symptom dimensions increased with the severity of CSI scores. Conclusions The current study successfully demonstrated additional evidence of the convergent and discriminant validity of the Serbian version of the CSI.

show abstract

Section: Introductionsupporting

confidence: 61%

Section: Introductionmentioning

confidence: 81%

Section: Introductionmentioning

confidence: 81%

See 1 more Smart Citation

Convergent and Discriminant Validity of the Serbian Version of the Central Sensitization Inventory

et al. 2020

Self Cite

View full text Add to dashboard Cite

show abstract

“…Higher dosages of analgesics and higher pain intensity correlated with higher CSI scores post‐surgically. Neblett, however, pointed out that a CSI score of <40 can be present in patients with CSS, and Tanaka et al identified patients diagnosed with CSSs who scored <40 on the CSI. Moreover, CSI cutoff scores seem to be culturally sensitive, since pain behavior is influenced not only by psychosocial factors but also by cultural ones .…”

Section: Introductionmentioning

confidence: 99%

Cross‐cultural Adaptation and Psychometric Properties of the Greek Version of the Central Sensitization Inventory

et al. 2020

Self Cite

View full text Add to dashboard Cite

Objectives Recent studies support the opinion that central sensitization (CS) plays an important role in the pathophysiology of many chronic pain conditions. CS refers to hyperexcitability of the central nervous system, which can result in pain hypersensitivity and other somatosensory symptoms. Recognition of CS‐related symptomology is crucial in chronic pain evaluation and rehabilitation. The Central Sensitization Inventory (CSI) was created to evaluate symptoms that have been found to be associated with CS. The aim of the current study was the cross‐cultural adaptation of the CSI into Greek (CSI‐Gr). Methods To evaluate discriminate validity, 200 patients with chronic pain and 50 healthy control subjects participated. The sample was divided into 4 diagnostic groups (fibromyalgia, single pain complaints, multiple pain complaints, and a control group) and into 5 CSI severity subgroups, from subclinical to extreme. Convergent validity was determined by evaluation of the relationship between the CSI‐Gr and the Pain Catastrophizing Scale (PCS). Additionally, 30 patients completed the CSI a second time for the purpose of a test/retest analysis. Results The results showed high internal consistency (Cronbach's alpha = 0.994) and test‐retest reliability (intraclass correlation coefficient = 0.993). The standard error of measurement was 2.1. The CSI‐Gr correlated moderately with the PCS (r = 0.68). Statistically significant differences were found among the 3 comparison groups, with patients who had fibromyalgia reporting the highest CSI severity and healthy control subjects reporting the lowest severity. Conclusions As determined in the present study, the CSI‐Gr was found to be a reliable and valid tool for recognition of CS‐related symptomology.

show abstract

“…Multiple language versions are available at: http://www.pridedallas.com/questionnaires. Neblett (this Issue) has provided a “User's Manual” for the CSI in this SPECIAL ISSUE.…”

Section: Assessment Methods For Central Sensitizationmentioning

confidence: 99%

Central Sensitization: A Brief Overview

Gatchel

Neblett

2018

J Appl Biobehavioral Res

Self Cite

View full text Add to dashboard Cite

This article introduces a SPECIAL ISSUE of the Journal of Applied Biobehavioral Research on Central Sensitization (CS). First, a general overview of CS is provided, including some historical perspective, the prevalence of CS in various chronic pain disorders, and common ways of measuring CS and related symptoms. Then a brief summary of each contributing article to this SPECIAL ISSUE is provided. Article topics include: CS-related neurobiology; diagnostic phenotyping; a biopsychosocial perspective of CS-related disorders; use of the Central Sensitization Inventory (CSI); evaluation of CS and related symptoms in some specific disorders (including general chronic pain, fibromyalgia, and breast cancer survivors); and how the concept of CS has changed our current view of chronic pain.

show abstract

The central sensitization inventory: A user’s manual

Cited by 73 publications

References 78 publications

Convergent and Discriminant Validity of the Serbian Version of the Central Sensitization Inventory

Convergent and Discriminant Validity of the Serbian Version of the Central Sensitization Inventory

Cross‐cultural Adaptation and Psychometric Properties of the Greek Version of the Central Sensitization Inventory

Central Sensitization: A Brief Overview

Contact Info

Product

Resources

About